CME in Minutes: Education in Dermatology

0
Life Sciences #61

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Dermatology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for dermatologists to cover the diagnosis, treatment, follow-up, and clinical management of various skin conditions. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.

More
Recent Episodes
  • Nathan Falk, MD, MBA, FAAFP - Making Sense of Type 2 Inflammation Crosstalk in Chronic Diseases: Perspectives on Improving Emergency and Primary Care Collaboration
    Apr 2, 2025 – 00:16:48
  • Sunandana Chandra, MD, MS - Practical Guidance on Managing Adverse Events Associated With Immunotherapy Regimens for Nonmelanoma Skin Cancers
    Dec 17, 2024 – 00:14:11
  • Erin Barrett (Wei), MD - Focusing on the Patient to Enhance Therapeutic Care: Advancing Early Diagnosis and Management of Bullous Pemphigoid
    Nov 29, 2024 – 00:15:10
  • Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
    Nov 6, 2024 – 00:15:35
  • Vishal A. Patel, MD - Selecting and Sequencing Systemic Treatment for Advanced Basal Cell Carcinoma
    Oct 28, 2024 – 00:13:42
  • Ahmad Tarhini, MD, PhD - Adjuvant Approaches in High-Risk, Resectable Melanoma: A Practical Guide to Improving Outcomes With Immunotherapy-Based Regimens
    Sep 19, 2024 – 00:14:24
  • David M. Miller, MD, PhD / Todd Schlesinger, MD - A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies
    Sep 13, 2024 – 00:16:17
  • Vasu Divi, MD, MS - Neoadjuvant Immunotherapy for CSCC: Practical Considerations for Resectability, Patient Selection, and Treatment Optimization
    Sep 9, 2024 – 00:12:35
  • Vibeke Strand, MD / April W. Armstrong, MD, MPH - A New Take on TYK2 Inhibitors: Bridging Gaps in Psoriatic Arthritis Management With Novel Targeted Therapies
    Sep 4, 2024 – 00:19:56
  • Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities
    Aug 16, 2024 – 00:18:09
  • Jonathan Silverberg, MD, PhD, MPH - Taking a Hands-On Approach to the Management of Moderate to Severe Hand and Foot Atopic Dermatitis: Enhancing Patient Outcomes With Novel Systemic Therapies
    Jul 4, 2024 – 00:14:08
  • Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
    Apr 5, 2024 – 00:12:52
  • Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
    Apr 5, 2024 – 00:14:09
  • Nikhil I. Khushalani, MD - Pointing the Way to Enhanced Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Practical Strategies to Incorporate Neoadjuvant Immunotherapy
    Feb 26, 2024 – 00:18:19
  • Evan J. Lipson, MD - Real Talk About Maximizing Care in Advanced Melanoma: Balancing Benefit and Risk Using Dual Immunotherapy Regimens
    Feb 14, 2024 – 00:13:24
  • Jonathan Barker, BSc, MB, BS, MD, FRCP - Novel Approved and Emerging IL-36 Receptor Inhibitors for the Treatment of GPP
    Jan 26, 2024 – 00:14:11
  • David M. Miller, MD, PhD / Kevin Emerick, MD - Coming Together to Improve Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Multidisciplinary Care Strategies With Neoadjuvant Immunotherapy
    Jan 3, 2024 – 00:14:25
  • Vishal A. Patel, MD - Making Headway in Treating Resectable Cutaneous Squamous Cell Carcinoma: Setting Sights on Neoadjuvant Immunotherapy
    Dec 18, 2023 – 00:14:21
  • Trisha Wise-Draper, MD, PhD - Empowering Precision Decisions: PD-1 Inhibitor-Based Therapies and Biomarker Testing in R/M HNSCC
    Oct 11, 2023 – 00:14:19
  • Shawn Kwatra, MD - Itching for Relief: Exploring the Role of Novel Biologics in Prurigo Nodularis
    Oct 6, 2023 – 00:16:57
  • Sapna P. Patel, MD - Enhancing Neoadjuvant and Adjuvant Treatment in Resectable Melanoma: Is Timing the Key to Improved Outcomes?
    Sep 19, 2023 – 00:14:54
  • Peter Lio, MD - Enriching Care for Pediatric Atopic Dermatitis: Evidence-Based Strategies for Integrating Targeted Systemic Therapies
    Aug 23, 2023 – 00:16:59
  • April W. Armstrong, MD, MPH - Looking Ahead: What the Future Holds for Novel Systemic Therapies in the Treatment of Moderate-to-Severe Atopic Hand and Foot Dermatitis
    Jul 3, 2023 – 00:14:20
  • Axel Hauschild, MD - Advancing Outcomes in Surgically Resectable Cutaneous Squamous Cell Carcinoma: Carving New Paths Forward With Immunotherapies
    Jun 15, 2023 – 00:12:56
  • Dirk Schadendorf, MD - An Evolution in Care for Advanced Melanoma: Exploring the Clinical Implications of Approved and Emerging Anti–LAG-3/PD-1 Combinations
    Jun 8, 2023 – 00:12:03
  • Hussein Tawbi, MD, PhD / Laura K. Ferris, MD, PhD - Optimizing Outcomes in Advanced Melanoma Through Enhanced Collaboration: A Real-World Multidisciplinary Approach
    May 4, 2023 – 00:14:33
  • Reinhard Dummer, Prof. Dr. med - Making the Case for a Systemic Approach to Advanced Basal Cell Carcinoma: A Multidisciplinary Team Strategy to Optimize Long-Term Care
    Mar 30, 2023 – 00:14:17
  • Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy
    Mar 16, 2023 – 00:13:56
  • Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis
    Mar 16, 2023 – 00:13:09
  • Omid Hamid, MD - An Expert Conversation About Anti-LAG-3/PD-1 Combinations: Exploring the Clinical Impact of Approved and Emerging Combinations in the Advanced Melanoma Treatment Landscape
    Dec 20, 2022 – 00:13:38
  • Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care
    Dec 13, 2022 – 00:13:44
  • Peter Lio, MD - More Than Scratching the Surface: Optimizing Novel JAK Inhibitors for Improved Outcomes in Moderate-to-Severe Atopic Dermatitis
    Dec 5, 2022 – 00:13:24
  • Latanya Benjamin, MD, FAAD, FAAP - Improving the Care of Children with Moderate-to-Severe Atopic Dermatitis: When and How to Intensify Treatment with Novel Systemic Agents
    Nov 16, 2022 – 00:12:09
  • Tanios Bekaii-Saab, MD / Beth McLellan, MD - Managing Hand-Foot Skin Reaction: Interdisciplinary Strategies for Patients on Multikinase Inhibitors
    Oct 4, 2022 – 00:15:56
  • Ikuo Hirano, MD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Diagnosing Promptly and Understanding Type 2 Inflammation
    Sep 26, 2022 – 00:13:32
  • Peter Lio, MD - Clinical Perspective on the Latest Data for Emerging Therapies Targeting IL-13 in Moderate-to-Severe Atopic Dermatitis
    Sep 2, 2022 – 00:15:13
Recent Reviews
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.